Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gatsios Leaving Healthlinx; New COO at Agilent; and More

Premium

Healthlinx said this week that CEO Nick Gatsios will resign as of June 30, 2012.

Gatsios was a founding director of the company when it launched in 2002 and has been its CEO since it went public on the Australian Stock Exchange in 2006. He is extending his contracted notice period by two months in order “to complete current projects of strategic importance,” the company said.

No reason was given for his departure.


Agilent this week appointed Ron Nersesian executive vice president and chief operating officer.

Prior to the appointment, Nersesian had been president of Agilent’s Electronic Measurement Group.


Sparton Corporation’s board of directors this week named Charles Kummeth an independent director.

Kummeth is president of Thermo Fisher Scientific’s Global Chromatography and Mass Spectrometry division.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.